Eurofins Scientific SE provided revenue guidance for the fiscal year 2024. For the year, the company expects revenue including M&A of 7,250 million.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
54.54 EUR | +0.52% | -2.01% | -7.53% |
05-31 | EUROFINS SCIENTIFIC : EPS cut (2023: -28.6%, 2024: -18.4%) | |
05-13 | Eurofins Scientific to Expand US Battery Materials Testing Capabilities | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.53% | 11.22B | |
+24.25% | 88.08B | |
-24.01% | 75.32B | |
+5.42% | 28.19B | |
+6.27% | 17.78B | |
-13.14% | 16.64B | |
+2.09% | 15.64B | |
+79.55% | 13.81B | |
+79.66% | 13.26B | |
+21.81% | 12.43B |
- Stock Market
- Equities
- ERF Stock
- News Eurofins Scientific SE
- Eurofins Scientific SE Provides Revenue Guidance for the Fiscal Year 2024